Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vergani

Showing results (161-170 of 249) with videos related to

Pageof 25
Sort By:
The Journal of Infection|January 1, 1994
Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virusG Senaldi, M Peakman, C Natoli, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective studyG V Gregorio, B Portmann, J Karani, et al.
Current Molecular Medicine|March 20, 2002
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunityL Wen, Y Ma, D P Bogdanos, et al.
Lancet (London, England)|August 9, 1980
Joint symptoms, immune complexes, and rubellaD Vergani, P Morgan-Capner, E T Davies, et al.
Journal of Internal Medicine|January 1, 1992
Radionuclide assessment of left ventricular function in patients with myocardial infarction and diabetes mellitusA Lomuscio, A Bestetti, D Vergani, et al.
Gastroenterology|December 1, 1989
Activation of the complement system in primary sclerosing cholangitisG Senaldi, P T Donaldson, S Magrin, et al.
Diabetes|May 1, 1994
Increased expression of T-cell markers of immunological memory associated with protection from type I diabetes. A study of identical twinsM Peakman, L Alviggi, M J Hussain, et al.
Cancer|September 15, 1983
Chronic liver disease in children with leukemia in long-term remissionA Locasciulli, G M Vergani, C Uderzo, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver diseaseY Ma, M Meregalli, S Hodges, et al.
Journal of Viral Hepatitis|October 4, 2014
HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapyI Carey, M Bruce, M Horner, et al.
Pageof 25

Showing results (161-170 of 249) with videos related to

Sort By:
Pageof 25
The Journal of Infection|January 1, 1994
Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virusG Senaldi, M Peakman, C Natoli, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective studyG V Gregorio, B Portmann, J Karani, et al.
Current Molecular Medicine|March 20, 2002
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunityL Wen, Y Ma, D P Bogdanos, et al.
Lancet (London, England)|August 9, 1980
Joint symptoms, immune complexes, and rubellaD Vergani, P Morgan-Capner, E T Davies, et al.
Journal of Internal Medicine|January 1, 1992
Radionuclide assessment of left ventricular function in patients with myocardial infarction and diabetes mellitusA Lomuscio, A Bestetti, D Vergani, et al.
Gastroenterology|December 1, 1989
Activation of the complement system in primary sclerosing cholangitisG Senaldi, P T Donaldson, S Magrin, et al.
Diabetes|May 1, 1994
Increased expression of T-cell markers of immunological memory associated with protection from type I diabetes. A study of identical twinsM Peakman, L Alviggi, M J Hussain, et al.
Cancer|September 15, 1983
Chronic liver disease in children with leukemia in long-term remissionA Locasciulli, G M Vergani, C Uderzo, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver diseaseY Ma, M Meregalli, S Hodges, et al.
Journal of Viral Hepatitis|October 4, 2014
HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapyI Carey, M Bruce, M Horner, et al.
Pageof 25